Cambridge Investment Research Advisors, Inc. Phibro Animal Health Corp Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 09, 2018	SELL	$32.2 - $40.45 $558,509 - $701,605	-17,345 Closed	0 $0
Q4 2017 Feb 22, 2018	BUY	$32.65 - $37.9 $75,780 - $87,965	2,321 Added 15.45%	17,345 $0
Q3 2017 Nov 07, 2017	BUY	$35.0 - $40.0 $525,840 - $600,960	15,024	15,024 $557,000

Others Institutions Holding PAHC

# of Institutions

149

Shares Held

20.4M

Call Options Held

Put Options Held

Black Rock Inc. New York, NY

3.5M
Shares

$70.3 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

1.49M
Shares

$30 Million
0.0% of portfolio
Brandes Investment Partners, LP La Jolla, CA

1.48M
Shares

$29.8 Million
0.4% of portfolio
Richard Pzena Pzena Investment Management LLC

1.46M
Shares

$29.3 Million
0.11% of portfolio
State Street Corp Boston, MA

905K
Shares

$18.1 Million
0.0% of portfolio

View Full List

About PHIBRO ANIMAL HEALTH CORP

Ticker PAHC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,337,600
Market Cap $408M
Description
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...

More about PAHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account